Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 169,061 | 154,688 | 125,249 | 149,706 | 141,517 |
| Cost of Goods | 19,467 | 15,217 | 11,698 | 14,836 | 13,279 |
| Gross Profit | 149,594 | 139,471 | 113,551 | 134,870 | 128,238 |
| Operating Expenses | 115,792 | 149,162 | 122,201 | 119,735 | 106,858 |
| Operating Income | 34,269 | -9,474 | -7,952 | 15,971 | 21,659 |
| Interest Expense | 11,711 | 11,565 | 11,455 | 11,958 | 12,692 |
| Other Income | 11,716 | 1,858 | 1,362 | 3,921 | -2,182 |
| Pre-tax Income | 34,274 | -19,181 | -18,045 | 7,934 | 6,785 |
| Income Tax | 16,968 | 5,239 | 3,641 | -6,805 | 13,514 |
| Net Income Continuous | 17,306 | -24,420 | -21,686 | 14,739 | -6,729 |
| Net Income | $17,306 | $-24,420 | $-21,686 | $14,739 | $-6,729 |
| EPS Basic Total Ops | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 |
| EPS Basic Continuous Ops | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 |
| EPS Diluted Total Ops | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 |
| EPS Diluted Continuous Ops | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.11 | -0.05 | -0.05 | 0.03 | 0.04 |
| EBITDA(a) | $36,801 | $-6,992 | $-5,509 | $18,609 | $24,403 |